Too funny by half.
Why rehash nappies?
Forgot asthma.
Forgot cohort b
Forgot manufacturing platform for everyone.
Not covered. Roberts report. Revenue models on one disease type.
A more serious tone on how we are blowing msb’s busi ness model would have been good.
And ross hates hotcopper. NSSherlck.
He wouldnt have to worry if he’d have got the stock to $3 before the crash!!!!
Biotech Daily - Dr Boreham’s Crucible: Cynata Therapeutics, page-3
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.005(1.82%) |
Mkt cap ! $48.78M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 26.5¢ | $71.17K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 145786 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |